ATE246507T1 - Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate - Google Patents
Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivateInfo
- Publication number
- ATE246507T1 ATE246507T1 AT00925158T AT00925158T ATE246507T1 AT E246507 T1 ATE246507 T1 AT E246507T1 AT 00925158 T AT00925158 T AT 00925158T AT 00925158 T AT00925158 T AT 00925158T AT E246507 T1 ATE246507 T1 AT E246507T1
- Authority
- AT
- Austria
- Prior art keywords
- anthracycline
- preparations containing
- platinum derivatives
- combined preparations
- containing morpholine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9909925.1A GB9909925D0 (en) | 1999-04-29 | 1999-04-29 | Combined preparations comprising anthracycline derivatives |
PCT/EP2000/002923 WO2000066093A2 (en) | 1999-04-29 | 2000-04-04 | Combined preparations comprising morpholine anthracyclines and anticancer agent |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE246507T1 true ATE246507T1 (de) | 2003-08-15 |
Family
ID=10852508
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03075776T ATE398457T1 (de) | 1999-04-29 | 2000-04-04 | Kombinationspräparat enthaltend ein morpholinyl anthracyclinderivat und einen topoisomerase ii inhibitor |
AT00925158T ATE246507T1 (de) | 1999-04-29 | 2000-04-04 | Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03075776T ATE398457T1 (de) | 1999-04-29 | 2000-04-04 | Kombinationspräparat enthaltend ein morpholinyl anthracyclinderivat und einen topoisomerase ii inhibitor |
Country Status (16)
Country | Link |
---|---|
US (2) | US6537990B1 (de) |
EP (3) | EP1173187B1 (de) |
JP (1) | JP2002543112A (de) |
CN (5) | CN1507869A (de) |
AR (1) | AR023616A1 (de) |
AT (2) | ATE398457T1 (de) |
AU (1) | AU4397700A (de) |
DE (2) | DE60004348T2 (de) |
DK (1) | DK1173187T3 (de) |
ES (2) | ES2307867T3 (de) |
GB (1) | GB9909925D0 (de) |
HK (1) | HK1045462B (de) |
MY (1) | MY136610A (de) |
PT (1) | PT1173187E (de) |
TW (1) | TWI222863B (de) |
WO (1) | WO2000066093A2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9916882D0 (en) * | 1999-07-19 | 1999-09-22 | Pharmacia & Upjohn Spa | Antitumor synergistic composition |
GB9920548D0 (en) * | 1999-08-31 | 1999-11-03 | Rhone Poulenc Rorer Sa | Treatment of hepatocellular carcinoma |
US20030133939A1 (en) * | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
US7829084B2 (en) | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
WO2002072085A1 (en) * | 2001-03-14 | 2002-09-19 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
CA2383259A1 (en) | 2002-04-23 | 2003-10-23 | Celator Technologies Inc. | Synergistic compositions |
US20080075762A1 (en) * | 2001-10-03 | 2008-03-27 | Paul Tardi | Compositions for delivery of drug combinations |
JP4502641B2 (ja) * | 2002-01-24 | 2010-07-14 | ティルタン ファーマ リミテッド | 抗癌組み合わせおよびその使用方法 |
TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
WO2004075904A1 (en) * | 2003-02-26 | 2004-09-10 | Pharmacia Italia Spa | Method for treating liver cancer by intrahepatic administration of nemorubicin |
CA2519310A1 (en) * | 2003-03-18 | 2004-09-30 | Maria Adele Pacciarini | Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor |
CN100500212C (zh) * | 2005-04-06 | 2009-06-17 | 山东蓝金生物工程有限公司 | 一种抗实体肿瘤药物组合物 |
SI1912675T1 (sl) * | 2005-07-25 | 2014-07-31 | Emergent Product Development Seattle, Llc | zmanjšanje števila celic B z uporabo molekul, ki se specifično vežejo na CD37 in CD20 |
US7776832B2 (en) * | 2006-04-21 | 2010-08-17 | Gem Pharmaceuticals, Llc | Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
MX363905B (es) | 2006-06-12 | 2019-04-08 | Aptevo Res & Development Llc | Proteinas de union multivalentes monocatenarias con funcion efectora. |
US20090004134A1 (en) * | 2006-09-08 | 2009-01-01 | Obeid Michel Sarkis | Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membrane |
WO2008092796A1 (en) * | 2007-01-29 | 2008-08-07 | Nerviano Medical Sciences S.R.L. | Antitumor combination comprising a morpholinyl anthracycline and an antibody |
EP2152236B1 (de) | 2007-05-11 | 2015-09-02 | Nerviano Medical Sciences S.r.l. | Pharmazeutische zusammensetzung eines anthrazyklins |
WO2009106549A2 (en) * | 2008-02-26 | 2009-09-03 | Nerviano Medical Sciences S.R.L. | Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents |
EP2132228B1 (de) | 2008-04-11 | 2011-06-22 | Emergent Product Development Seattle, LLC | Cd37-immuntherapeutikum und kombination mit bifunktionellem chemotherapeutikum davon |
US8690833B2 (en) | 2011-01-31 | 2014-04-08 | Vascular Pathways, Inc. | Intravenous catheter and insertion device with reduced blood spatter |
CA2972065A1 (en) | 2014-12-23 | 2016-06-30 | Intellectual Property Associates, Llc | Methods and formulations for transdermal administration |
WO2017053469A2 (en) | 2015-09-21 | 2017-03-30 | Aptevo Research And Development Llc | Cd3 binding polypeptides |
US20190083386A1 (en) | 2017-09-15 | 2019-03-21 | Ampersand Biopharmaceuticals, Inc. | Methods and formulations for transdermal administration of buffering agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4710564A (en) * | 1985-01-18 | 1987-12-01 | Microbial Chemistry Research Foundation | Anthracycline compounds |
GB2172594B (en) * | 1985-03-22 | 1988-06-08 | Erba Farmitalia | New morpholino derivatives of daunorubicin and doxorubicin |
US5902809A (en) * | 1997-07-03 | 1999-05-11 | Paracure, Inc. | Arglabin compounds and therapeutic uses thereof |
GB9806324D0 (en) * | 1998-03-24 | 1998-05-20 | Pharmacia & Upjohn Spa | Antitumour synergetic composition |
GB9820012D0 (en) * | 1998-09-14 | 1998-11-04 | Pharmacia & Upjohn Spa | Use of an anthracycline derivative for the treatment of a liver tumor |
-
1999
- 1999-04-29 GB GBGB9909925.1A patent/GB9909925D0/en not_active Ceased
-
2000
- 2000-04-04 AU AU43977/00A patent/AU4397700A/en not_active Abandoned
- 2000-04-04 EP EP00925158A patent/EP1173187B1/de not_active Expired - Lifetime
- 2000-04-04 US US09/926,392 patent/US6537990B1/en not_active Expired - Fee Related
- 2000-04-04 EP EP08157789A patent/EP1977753A1/de not_active Withdrawn
- 2000-04-04 PT PT00925158T patent/PT1173187E/pt unknown
- 2000-04-04 DE DE60004348T patent/DE60004348T2/de not_active Expired - Lifetime
- 2000-04-04 EP EP03075776A patent/EP1323423B1/de not_active Expired - Lifetime
- 2000-04-04 DK DK00925158T patent/DK1173187T3/da active
- 2000-04-04 CN CNA2003101149119A patent/CN1507869A/zh active Pending
- 2000-04-04 CN CNA2006100597018A patent/CN1853645A/zh active Pending
- 2000-04-04 CN CNB008068976A patent/CN1222294C/zh not_active Expired - Fee Related
- 2000-04-04 ES ES03075776T patent/ES2307867T3/es not_active Expired - Lifetime
- 2000-04-04 ES ES00925158T patent/ES2204572T3/es not_active Expired - Lifetime
- 2000-04-04 WO PCT/EP2000/002923 patent/WO2000066093A2/en active IP Right Grant
- 2000-04-04 CN CNA2003101149091A patent/CN1535688A/zh active Pending
- 2000-04-04 JP JP2000614978A patent/JP2002543112A/ja active Pending
- 2000-04-04 AT AT03075776T patent/ATE398457T1/de not_active IP Right Cessation
- 2000-04-04 CN CNA2006100597037A patent/CN1853642A/zh active Pending
- 2000-04-04 AT AT00925158T patent/ATE246507T1/de not_active IP Right Cessation
- 2000-04-04 DE DE60039260T patent/DE60039260D1/de not_active Expired - Lifetime
- 2000-04-12 TW TW089106805A patent/TWI222863B/zh not_active IP Right Cessation
- 2000-04-26 MY MYPI20001780A patent/MY136610A/en unknown
- 2000-04-27 AR ARP000101989A patent/AR023616A1/es unknown
-
2002
- 2002-09-26 HK HK02107029.8A patent/HK1045462B/zh not_active IP Right Cessation
- 2002-10-31 US US10/284,144 patent/US6586428B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60039260D1 (de) | 2008-07-31 |
CN1222294C (zh) | 2005-10-12 |
AU4397700A (en) | 2000-11-17 |
WO2000066093A3 (en) | 2001-01-25 |
DK1173187T3 (da) | 2003-10-20 |
US20030087839A1 (en) | 2003-05-08 |
GB9909925D0 (en) | 1999-06-30 |
DE60004348D1 (de) | 2003-09-11 |
JP2002543112A (ja) | 2002-12-17 |
DE60004348T2 (de) | 2004-02-26 |
EP1173187B1 (de) | 2003-08-06 |
MY136610A (en) | 2008-10-31 |
ES2204572T3 (es) | 2004-05-01 |
CN1853645A (zh) | 2006-11-01 |
WO2000066093A2 (en) | 2000-11-09 |
CN1349406A (zh) | 2002-05-15 |
TWI222863B (en) | 2004-11-01 |
EP1323423A1 (de) | 2003-07-02 |
PT1173187E (pt) | 2003-10-31 |
AR023616A1 (es) | 2002-09-04 |
CN1535688A (zh) | 2004-10-13 |
EP1323423B1 (de) | 2008-06-18 |
US6537990B1 (en) | 2003-03-25 |
CN1853642A (zh) | 2006-11-01 |
US6586428B2 (en) | 2003-07-01 |
ES2307867T3 (es) | 2008-12-01 |
HK1045462B (zh) | 2006-04-28 |
EP1977753A1 (de) | 2008-10-08 |
ATE398457T1 (de) | 2008-07-15 |
EP1173187A2 (de) | 2002-01-23 |
HK1045462A1 (en) | 2002-11-29 |
CN1507869A (zh) | 2004-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE246507T1 (de) | Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate | |
ZA200102588B (en) | Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use. | |
IL152448A0 (en) | 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same | |
MXPA03003246A (es) | Derivados de indolina y su uso como ligandos del receptor 5-ht2. | |
ZA200007638B (en) | Pyrazoline derivatives, their preparation and application as medicaments. | |
HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
NO20011216L (no) | Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene | |
HUP0105414A3 (en) | Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them | |
MXPA02001508A (es) | Derivados de arilmetil-carbonilamino-tiazol y sus usos como agentes antitumorales. | |
NO20021379D0 (no) | Benzodiazepin-derivater, fremstilling og anvendelse derav | |
MXPA03004644A (es) | Derivados de fenilacetamdia-pirazol y su uso como agentes antitumorales. | |
HUP0401648A3 (en) | 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same | |
HUP0105003A3 (en) | 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them | |
PL344346A1 (en) | Platinum complex, its preparation and therapeutic application | |
ZA993345B (en) | Nefazodone dosage form. | |
HUP0400551A2 (en) | Piperazine derivatives, their preparation and pharmaceutical compositions containing them | |
PL366378A1 (en) | Benzoxazinone derivatives, their preparation and use | |
ATE266637T1 (de) | 3,3-biarylpiperidin- und 3,3- biarylmorpholinderivate | |
MXPA03000644A (es) | Nuevos derivados de indol y uso como medicamentos. | |
DE50002417D1 (de) | 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung | |
HUP0203839A3 (en) | 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives, pharmaceutical compositions containing them and their use | |
HUP0004981A3 (en) | Cosmetic composition containing an aminophenol derivative, its use and process for dissolving aminophenol derivatives | |
DE60144456D1 (de) | DibenzoÄb,fÜazepin-Derivate und ihre Herstellung | |
PL344345A1 (en) | Platinum complex, its preparation and therapeutic application | |
HUP0400154A3 (en) | Heterocondesated benzoxazepine and benzoxathiazepine derivatives, their use and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1173187 Country of ref document: EP |
|
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |